Shiv Kumar Prajapati

7PUBLICATIONS
6CO-AUTHORS
Pharmaceutical delivery technologiesMolecular targetsGene and molecular therapyQuality assurance, chemometrics, traceability and metrological chemistryBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 05, 2026
DoE-oriented optimization of a chitosan-based nanoemulgel of clobetasol propionate for therapeutic intervention in psoriasis.

|Feb 19, 2026
Mechanistic and translational frontiers on "VEGF and TKI inhibitor axitinib": unfolding drug delivery approaches and opportunities in cancer therapy.

Divya Sharma, Shiv Kumar Prajapati, Sweta Acharya

|Jul 24, 2025
Targeting rheumatoid arthritis: a molecular perspective on biologic therapies and clinical progress.

Ankit Jain, Mamta Bishnoi, Shiv Kumar Prajapati

|Mar 12, 2025
Lipid-based nanoformulations in onychomycosis therapy: addressing challenges of current therapies and advancing treatment.

Shiv Kumar Prajapati, Ankit Jain, Meenakshi Bajpai

|Jul 17, 2024
Development and validation of the RP-HPLC method for quantification of tavaborole.

Shiv Kumar Prajapati, Ankit Jain, Meenakshi Bajpai

|Mar 26, 2021
Exploring the room for repurposed hydroxychloroquine to impede COVID-19: toxicities and multipronged combination approaches with pharmaceutical insights.

Ankit Jain, Shiv Kumar Prajapati, Madhavi Tripathi

Pageof 2

Frequent Collaborators

6 joint publications

Ankit Jain

3 joint publications

Meenakshi Bajpai

1 joint publications

Ashok M Raichur

1 joint publications

Jagat R Kanwar